Laurus Labs completes USFDA inspection at facility in Andhra Pradesh

05 Nov 2018 Evaluate

Laurus Labs has successfully completed the US Food and Drug Administration (USFDA) inspection of its unit-6 API intermediate facility with one observation, which is related to a procedure, on November 02, 2018.

The manufacturing facility unit-6 is located at Atchutapuram in Visakhapatnam, Andhra Pradesh and has 42 reactors with 253 kilo-liters capacity.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

586.80 5.35 (0.92%)
18-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1748.60
Dr. Reddys Lab 1164.70
Cipla 1508.70
Lupin 2035.30
Zydus Lifesciences 903.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...